Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Oral Alpan"'
Publikováno v:
Frontiers in Allergy, Vol 4 (2023)
BackgroundBasophils normally make up
Externí odkaz:
https://doaj.org/article/afef12b84f8f43f3b65ca9ee83941342
Autor:
Oral Alpan, Richard L. Wasserman, Theodore Kim, Amy Darter, Atul Shah, Douglas Jones, Donald McNeil, Henry Li, Laura Ispas, Melinda Rathkopf, Elena Perez, Dareen Siri, Maeve O’Connor, Matthew Plassmeyer, Kimberly Romito, Christina Pettibone, Sean O’Reilly, Søren Ulrik Sønder, Gerald Marti
Publikováno v:
Frontiers in Allergy, Vol 3 (2023)
Food allergy is a global health problem affecting up to 10% of the world population. Accurate diagnosis of food allergies, however, is still a major challenge in medical offices and for patients seeking alternative avenues of diagnosis. A flawless te
Externí odkaz:
https://doaj.org/article/878eb1c99f424103b1befa541bdcb37b
Autor:
Stanley J. Szefler, Graham Roberts, Adalberto S. Rubin, Stefan Zielen, Piotr Kuna, Oral Alpan, Judith Anzures‐Cabrera, Qiang Chen, Cécile T. J. Holweg, Janusz Kaminski, Wendy S. Putnam, John G. Matthews, Nikhil Kamath
Publikováno v:
Clinical and Translational Allergy, Vol 12, Iss 7, Pp n/a-n/a (2022)
Abstract Background Lebrikizumab is a monoclonal antibody that modulates activity of interleukin‐13. The Phase 3 ACOUSTICS study assessed lebrikizumab efficacy and safety in adolescents with uncontrolled asthma despite standard‐of‐care treatmen
Externí odkaz:
https://doaj.org/article/95330c9a733f48b0baef545bd3c87bf6
Autor:
Bruce K. Patterson, Harish Seethamraju, Kush Dhody, Michael J. Corley, Kazem Kazempour, Jay Lalezari, Alina P.S. Pang, Christopher Sugai, Eisa Mahyari, Edgar B. Francisco, Amruta Pise, Hallison Rodrigues, Helen L. Wu, Gabriela M. Webb, Byung S. Park, Scott Kelly, Nader Pourhassan, Alina Lelic, Lama Kdouh, Monica Herrera, Eric Hall, Benjamin N. Bimber, Matthew Plassmeyer, Raavi Gupta, Oral Alpan, Jane A. O’Halloran, Philip A. Mudd, Enver Akalin, Lishomwa C. Ndhlovu, Jonah B. Sacha
Publikováno v:
International Journal of Infectious Diseases, Vol 103, Iss , Pp 25-32 (2021)
Objective: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is now a global pandemic. Emerging results indicate a dysregulated immune response. Given the role of CCR5 in immune cell migration and inflammation, we investigat
Externí odkaz:
https://doaj.org/article/aa64df75735341c59242e660d8c57951
Autor:
Thomas A. Premeaux, Stephen T. Yeung, Zaheer Bukhari, Scott Bowler, Oral Alpan, Raavi Gupta, Lishomwa C. Ndhlovu
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a significant global health emergency with new variants in some cases evading current therapies and approved vaccines. COVID-19 pr
Externí odkaz:
https://doaj.org/article/05b28cfe031e491a84bb5f026c68ac59
Autor:
Mikail Dogan, Lina Kozhaya, Lindsey Placek, Courtney Gunter, Mesut Yigit, Rachel Hardy, Matthew Plassmeyer, Paige Coatney, Kimberleigh Lillard, Zaheer Bukhari, Michael Kleinberg, Chelsea Hayes, Moshe Arditi, Ellen Klapper, Noah Merin, Bruce Tsan-Tang Liang, Raavi Gupta, Oral Alpan, Derya Unutmaz
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-13 (2021)
Using SARS-CoV-2-specific antibody- and neutralization assays, Dogan et al find that hospitalized individuals show higher IgG antibody responses and higher neutralization titers compared to outpatient or convalescent plasma donors, providing insights
Externí odkaz:
https://doaj.org/article/0a236342fbca4be7ad7450120dc25e6b
Autor:
Elena E. Perez, Jacques Hébert, Anne K. Ellis, Oral Alpan, William R. Lumry, Ralph Shapiro, Daniel Suez, J. Fernando Mandujano, Richard L. Wasserman
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
We report here the results of a phase 3 study to assess the efficacy, safety, and tolerability of GC5107, a new 10% liquid intravenous immunoglobulin (IVIG) in preventing serious bacterial infections in patients with primary immunodeficiency (Clinica
Externí odkaz:
https://doaj.org/article/298963e7f7c54d33b37e355269dbec5e
Autor:
Daniel J. Lovell, Jason A. Dare, Megan Francis-Sedlak, Julie Ball, Brian D. LaMoreaux, Emily Von Scheven, Adam Reinhardt, Rita Jerath, Oral Alpan, Ramesh Gupta, Donald Goldsmith, Andrew Zeft, Henry Naddaf, Beth Gottlieb, Lawrence Jung, Robert J. Holt
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 16, Iss 1, Pp 1-11 (2018)
Abstract Background Juvenile idiopathic arthritis (JIA) is an inflammatory arthritis of unknown etiology, which lasts for greater than 6 weeks with onset before 16 years of age. JIA is the most common chronic rheumatic disease in children. NSAIDs hav
Externí odkaz:
https://doaj.org/article/658608596cc5457f97ed2f7a51f86676
Publikováno v:
Case Reports in Gastroenterology, Vol 7, Iss 3, Pp 363-368 (2013)
Sublingual immunotherapy (SLIT) is increasingly investigated and utilized for the treatment of food and pollen allergies. Previous case reports suggested that eosinophilic esophagitis (EoE) might develop as a long-term complication in children after
Externí odkaz:
https://doaj.org/article/dd8f0c5a402f4922895558dd03bb7095
Autor:
Renuka Pudi Limgala, Chidima Ioanou, Matthew Plassmeyer, Mark Ryherd, Lina Kozhaya, Lauren Austin, Cem Abidoglu, Derya Unutmaz, Oral Alpan, Ozlem Goker-Alpan
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0168135 (2016)
Gaucher disease (GD) patients often present with abnormalities in immune response that may be the result of alterations in cellular and/or humoral immunity. However, how the treatment and clinical features of patients impact the perturbation of their
Externí odkaz:
https://doaj.org/article/6a7e07c2268f41acb2125d2f1d52a418